Home > Insider Trading > Filing (0001209191-22-053659)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1720580	Adicet Bio Inc.	ACET	Pharmaceutical Preparations (2834)	813305277

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1886986	Blake Aftab	C/O Adicet Bio, Inc. 200 Berkeley Street, 19Th Floor Boston MA 02116	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-10-12	3,388	$7.38	52,822	No	4	M	Direct
Common Stock	Disposition	2022-10-12	1,646	$15.40	51,176	No	4	S	Direct
Common Stock	Disposition	2022-10-13	7,933	$15.92	43,243	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-10-12	3,388	$0.00	3,388	$7.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
56,612		2031-10-11	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
A total of 60,000 shares subject to an employee stock option were granted to the Reporting Person on October 12, 2021. 25% of the shares subject to the stock option vested and became exercisable on October 12, 2022, with the remainder vesting in equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continued service with the Issuer.